HLA class II DQA and DQB epitopes: Recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines

被引:32
作者
El-Awar, Nadim [1 ]
Anh Nguyen [1 ]
Almeshari, Khalid [2 ]
Alawami, Moheeb [3 ]
Alzayer, Fadi [3 ]
Alharbi, Maha [3 ]
Sasaki, Nori [1 ]
Terasaki, Paul I. [4 ]
机构
[1] One Lambda Inc, Canoga Pk, CA USA
[2] King Faisal Specialist Hosp & Res Ctr, Dept Kidney & Pancreas Transplantat, Riyadh 11211, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Histocompatibil & Immunogenet Lab, Riyadh 11211, Saudi Arabia
[4] Terasaki Lab Fdn, Los Angeles, CA USA
关键词
DONOR-SPECIFIC ANTIBODIES; 3-DIMENSIONAL STRUCTURE; TRANSPLANTATION; COMPLEX;
D O I
10.1016/j.humimm.2013.05.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Donor-specific antibodies (DSA) in sera of sensitized transplant patients are often produced against the specific epitopes on mismatched HLA antigens. In this study, we selected sera from 30 kidney transplant patients with DSA and AMR to define DQ epitopes. Using adsorption and elution assays, we identified 18 antibody reaction patterns to define 6 new epitopes and to confirm 12 previously defined epitopes. In one patient case, one mismatched antigen produced 3 different antibodies and, in another, antibodies were produced against the alpha and beta chains of the same antigen. For some sera, a single epitope can explain reactions for 27 of the 29 DQ beads in the single antigen panel. Several studies highlighted the prevalence of anti-DQ antibodies. In 2011, Almeshari et al. observed DQ DSA in 34/46 (74%) of rejection episodes 44 patients had DSA and 20 lost their graft due to AMR. Other studies have shown a high prevalence of anti-DQ antibodies and an association with adverse effects on the graft. We conclude that analysis of the epitopes of the DQ antibodies using Adsorption/Elution and testing on single antigen DQ beads helps to better understand the specificities and cross-reactions of DQ antibodies in transplant patients. (C) 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1141 / 1152
页数:12
相关论文
共 15 条
[1]  
Almeshari K, 2011, Clin Transpl, P395
[2]   3-DIMENSIONAL STRUCTURE OF AN ANTIGEN-ANTIBODY COMPLEX AT 2.8-A RESOLUTION [J].
AMIT, AG ;
MARIUZZA, RA ;
PHILLIPS, SEV ;
POLJAK, RJ .
SCIENCE, 1986, 233 (4765) :747-753
[3]   Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients [J].
Deng, Chun-Tsan ;
El-Awar, Nadim ;
Ozawa, Miyuki ;
Cai, Junchao ;
Lachmann, Nils ;
Terasaki, Paul I. .
TRANSPLANTATION, 2008, 86 (03) :452-459
[4]   Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation [J].
DeVos, Jennifer M. ;
Gaber, A. Osama ;
Knight, Richard J. ;
Land, Geoffrey A. ;
Suki, Wadi N. ;
Gaber, Lillian W. ;
Patel, Samir J. .
KIDNEY INTERNATIONAL, 2012, 82 (05) :598-604
[5]   Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes [J].
Duquesnoy, Rene J. ;
Awadalla, Yehia ;
Lomago, Jon ;
Jelinek, Larry ;
Howe, Judy ;
Zern, Dwayne ;
Hunter, Betty ;
Martell, Joan ;
Girnita, Alin ;
Zeevi, Adriana .
TRANSPLANT IMMUNOLOGY, 2008, 18 (04) :352-360
[6]   HLA class I epitopes: Recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens [J].
El-Awar, Nadim ;
Lee, Jar-How ;
Tarsitani, Christine ;
Terasaki, Paul I. .
HUMAN IMMUNOLOGY, 2007, 68 (03) :170-180
[7]   Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation [J].
Hourmant, M ;
Cesbron-Gautier, A ;
Terasaki, PI ;
Mizutani, K ;
Moreau, A ;
Meurette, A ;
Dantal, J ;
Giral, M ;
Blancho, G ;
Cantarovich, D ;
Karam, G ;
Follea, G ;
Soulillou, JP ;
Bignon, JD .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (09) :2804-2812
[8]   Humoral immune reactivity against human leukocyte antigen (HLA)-DQ graft molecules in the early posttransplantation period [J].
Iniotaki-Theodoraki, AG ;
Boletis, JN ;
Trigas, GC ;
Kalogeropoulou, HG ;
Kostakis, AG ;
Stavropoulos-Giokas, CG .
TRANSPLANTATION, 2003, 75 (09) :1601-1603
[9]  
Khalid Al Meshari, 2011, HUM IMMUNOL S, V72, P187
[10]  
Kim C, CRYSTAL STRUCTURE HL